Two international academic journals have found that it is effective to apply classical treatments to patients with advanced ...

These features of hepatic injury distinguish MASH from MASLD ... Dudzinski: Surveillance abdominal ultrasonography for hepatocellular carcinoma was performed at the third hospital at 12-month ...

Advanced hepatocellular carcinoma (HCC) with pulmonary metastasis (PM) has a poor prognosis, and optimal treatment strategies remain controversial. This study compared pulmonary metastasectomy and ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with over 70% of patients diagnosed at ...

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver ...

WEDNESDAY, March 19, 2025 (HealthDay News) -- For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation ...

Findings from the CheckMate 9DW trial support the FDA approval of nivolumab and ipilimumab in unresectable hepatocellular ...

There was no significant difference in overall survival between the two groups at 1 year (all trials reported this data, OR: 0.84, 95% CI: 0.58–1.21), and at 2 years (four trials reported this ...